Ars Technica May 13, 2026 at 10:00 Big Tech Stable Warm

Could this be the moment that drug manufacturing takes off in orbit?

"I do think it's a really good historical moment for the space industry."

Signal weather

Stable

The story has moved beyond the first headline and now acts as a reliable context anchor.

By Eric Berger Original source

Could this be the moment that drug manufacturing takes off in orbit?

NASA has enabled scientists to study the impact of microgravity on drug development for decades, beginning with the Space Shuttle. This work accelerated in the 2010s, with the completion of the International Space Station and full-time crew members devoted to scientific research. There have been some notable successes during this timeframe, such as the ability to grow a more uniform crystalline form of the cancer drug Keytruda in 2019. This opened up the possibility of administering the drug via injection rather than requiring a patient to spend hours in a clinic setting to receive the drug intravenously. NASA subsidized much of this work, typically paying the considerable costs to transport research to the ISS and for astronaut time to conduct research there. There were, however, trade-offs, such as long lead times to get research into space. Nevertheless, it has become clear that there could be some commercial applications for making drugs in space. Read full article Comments

Read the full article

Stay on the signal

Follow Could this be the moment that drug manufacturing takes off in orbit?

Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.

Story map

Understand this topic fast

A quick entry into the story: why it matters now, who is involved, and where to go next for context.

Why it matters now

This story is still moving and pulling follow-up coverage.

There are already 6 connected articles in the same storyline to continue from here.

The story keeps orbiting around Ars Technica, Drug Manufacturing, and Historical, so the entity pages are the fastest way to build context.

Ars Technica already has 4 follow-up stories on the same theme.

Topic constellation

Open the live map for this story

See which entities, story threads, sources, and follow-up articles shape this story right now.

Click nodes to continue

Entity Cluster Article Hub Source

Entity pages

Ars Technica Drug Manufacturing Historical Historical Moment Industry Manufacturing

Story threads

Ars Technica

Latest coverage and related links about Ars Technica.

Ars Technica

Последние материалы и связанный контекст по теме Ars Technica.

Historical

Последние материалы и связанный контекст по теме Historical.

Industry

Последние материалы и связанный контекст по теме Industry.

Story timeline

Continue with this story

A short sequence of events and follow-up stories to understand the arc quickly.

Jun 28, 2026 at 18:49 Ars Technica

Why did this journal retract two 1940s papers by Max Planck?

Clicking on the links now reveals blank pages and empty PDFs. "Intellectually, it’s not acceptable.”

Jun 28, 2026 at 18:32 Hacker News

Historical memory prices 1960-2026

Comments

Jun 27, 2026 at 11:07 Ars Technica

Apple and Audi alumni have made a luxe EV based on the moon buggy

The Amble One is a street-legal $25,000 electric buggy designed for luxury resorts.

Jun 26, 2026 at 22:19 Ars Technica

South Korea plans to train entire military as "drone warriors"

Half-million strong military will train on drones as “universal combat tool.”